Johnson & Johnson vaccine passes FDA expert panel, expected to ship 3.9M doses next week
On Friday, the FDA’s team of outside expert sat down in front of their cameras to participate in something that’s becoming almost routine—the review of a new COVID-19 vaccine. This time they were looking at the single-shot vaccine from Johnson & Johnson. At the end of the discussion, the panel voted unanimously to recommend approval of the vaccine’s use in the current emergency.





























